Skip to content
Disclosery

EXANE DERIVATIVES: PG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,705 PG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,705 shares
    Change vs previous 13F -145 shares

    0.31% of the 13F portfolio, value $532,677.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,850 shares
    Change vs previous 13F -440 shares

    0.17% of the 13F portfolio, value $588,284.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,290 shares
    Change vs previous 13F -500 shares

    0.17% of the 13F portfolio, value $701,781.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,790 shares
    Change vs previous 13F -572 shares

    0.17% of the 13F portfolio, value $669,668.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 5,362 shares
    Change vs previous 13F -656 shares

    0.17% of the 13F portfolio, value $734,450.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 6,018 shares
    Change vs previous 13F -2,356 shares

    0.25% of the 13F portfolio, value $815,055.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 8,374 shares
    Change vs previous 13F +1,351 shares

    0.35% of the 13F portfolio, value $1,165,210.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 7,023 shares
    Change vs previous 13F not available

    0.32% of the 13F portfolio, value $976,153.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).